Cart
sales@molnova.com
FPR A14
CAS No. 329691-12-5
FPR A14( —— )
Catalog No. M33853 CAS No. 329691-12-5
FPR A14 is an agonist of formyl peptide receptor (FPR) and induces cell differentiation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 41 | In Stock |
|
| 10MG | 69 | In Stock |
|
| 25MG | 145 | In Stock |
|
| 50MG | 247 | In Stock |
|
| 100MG | 360 | In Stock |
|
| 200MG | 512 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFPR A14
-
NoteResearch use only, not for human use.
-
Brief DescriptionFPR A14 is an agonist of formyl peptide receptor (FPR) and induces cell differentiation.
-
DescriptionFPR-A14 is a potent formyl peptide receptor (FPR) agonist. FPR-A14 is a potent activator of neutrophil Ca2+ mobilization and chemotaxis with EC50s of 630 nM and 42 nM, respectively. FPR-A14 induces cell differentiation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number329691-12-5
-
Formula Weight404.42
-
Molecular FormulaC23H20N2O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (309.08 mM; Ultrasonic (<60°C)
-
SMILESCOc1cc(\C=N\NC(=O)c2ccc3OCOc3c2)ccc1OCc1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Igor A Schepetkin, et al. High-throughput screening for small-molecule activators of neutrophils: identification of novel N-formyl peptide receptor agonists. Mol Pharmacol. 2007 Apr;71(4):1061-74.?
molnova catalog
related products
-
N-Boc-Phe-Leu-Phe-Le...
N-Boc-Phe-Leu-Phe-Leu-Phe (Boc-FLFLF) is a formyl peptide receptor 1 (FPR1) antagonist, which increases pain effects and inhibits antinociceptive activity of annexin. Boc-Phe-Leu-Phe-Leu-Phe is used extensively in FPR research.
-
Homoveratronitrile
Used in organic synthesis, medicine industry.
-
Lupanine
Lupanine has a weak sedative effect on the central nervous system, interaction with specific drugs used for treatment of the CNS and for analgesic activity. Lupanine improves glucose homeostasis by influencing KATP-channels of pancreatic beta cells.
